A Japanese lung cancer registry study at 2002: Japanese joint committee for lung cancer registration

Noriyoshi Sawabata, Hisao Asamura, Tomoyuki Goya, Masaki Mori, Yoichi Nakanishi, Kenji Eguchi, Yoshihiko Koshiishi, Ryosuke Tsuchiya, Meinoshin Okumura, Etsuo Miyaoka, Yoshitaka Fujii

研究成果: Article

2 引用 (Scopus)

抄録

Objectives. To publicize clinical results of Japanese lung cancer patients registered in 2002. Study Design. In 2002, The Japanese Joint Committee for Lung Cancer Registration conducted a prospective observational study for lung cancer patients registered at starting treatments with follow-ups in 2004 and 2009. At first, 18,552 cases were registered from 358 institutes, while we analyzed 14,695 samples whose living periods could be identified. Results. There were 2 times males as many as females with a mean age of 67.1 years. The most frequent histology was adenocarcinoma in 56.7%, following squamous cell carcinoma in 25.7% and small cell carcinoma in 9.2%. Clinical stage was IA in 29.3%, IB in 15.3%, IIA in 1.4%, IIB in 6.2%, IIIA in 11.8%, IIIB in 14.6% and IV in 21.0%. Surgery was performed in 8,454 cases (57.5%). Five-year survival rate was 44.3% for all patients, 14.7% for cases of small cell carcinoma, 46.8% for non small cell carcinoma, 59.6% for surgery cases, 8.5% for no surgery cases, 37.7% for males and 59.0% for females. The rates in clinical stage settings in cases of small cell carcinoma and non small cell carcinoma, was 52.7% and 79.4% for IA, 39.3% and 56.9% for IB, 31.7% and 49.0% for IIA, 29.9% and 42.3% for IIB, 17.2% and 30.9% for IIIA, 12.4% and 16.7% for IIIB and 3.8% and 5.8% for IV, respectively. Conclusion. An analysis of Japanese lung cancer patients registered in 2002 revealed that the most frequent histology type was adenocarcinoma following squamous cell carcinoma and small cell carcinoma. Prognosis in 5 years was superior in cases of female, non small cell lung cancer and surgery to those of male, small cell lung cancer and no surgery, respectively. Further investigation is needed with respect to dependences of those survival differences.

元の言語English
ページ(範囲)975-987
ページ数13
ジャーナルJapanese Journal of Lung Cancer
49
発行部数7
DOI
出版物ステータスPublished - 2009 12
外部発表Yes

Fingerprint

Small Cell Carcinoma
Registries
Lung Neoplasms
Squamous Cell Carcinoma
Histology
Adenocarcinoma
Small Cell Lung Carcinoma
Non-Small Cell Lung Carcinoma
Observational Studies
Survival Rate
Prospective Studies
Survival

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

これを引用

A Japanese lung cancer registry study at 2002 : Japanese joint committee for lung cancer registration. / Sawabata, Noriyoshi; Asamura, Hisao; Goya, Tomoyuki; Mori, Masaki; Nakanishi, Yoichi; Eguchi, Kenji; Koshiishi, Yoshihiko; Tsuchiya, Ryosuke; Okumura, Meinoshin; Miyaoka, Etsuo; Fujii, Yoshitaka.

:: Japanese Journal of Lung Cancer, 巻 49, 番号 7, 12.2009, p. 975-987.

研究成果: Article

Sawabata, N, Asamura, H, Goya, T, Mori, M, Nakanishi, Y, Eguchi, K, Koshiishi, Y, Tsuchiya, R, Okumura, M, Miyaoka, E & Fujii, Y 2009, 'A Japanese lung cancer registry study at 2002: Japanese joint committee for lung cancer registration', Japanese Journal of Lung Cancer, 巻. 49, 番号 7, pp. 975-987. https://doi.org/10.2482/haigan.49.975
Sawabata, Noriyoshi ; Asamura, Hisao ; Goya, Tomoyuki ; Mori, Masaki ; Nakanishi, Yoichi ; Eguchi, Kenji ; Koshiishi, Yoshihiko ; Tsuchiya, Ryosuke ; Okumura, Meinoshin ; Miyaoka, Etsuo ; Fujii, Yoshitaka. / A Japanese lung cancer registry study at 2002 : Japanese joint committee for lung cancer registration. :: Japanese Journal of Lung Cancer. 2009 ; 巻 49, 番号 7. pp. 975-987.
@article{91c37fa3f84444f3b9a33c4cb02c088c,
title = "A Japanese lung cancer registry study at 2002: Japanese joint committee for lung cancer registration",
abstract = "Objectives. To publicize clinical results of Japanese lung cancer patients registered in 2002. Study Design. In 2002, The Japanese Joint Committee for Lung Cancer Registration conducted a prospective observational study for lung cancer patients registered at starting treatments with follow-ups in 2004 and 2009. At first, 18,552 cases were registered from 358 institutes, while we analyzed 14,695 samples whose living periods could be identified. Results. There were 2 times males as many as females with a mean age of 67.1 years. The most frequent histology was adenocarcinoma in 56.7{\%}, following squamous cell carcinoma in 25.7{\%} and small cell carcinoma in 9.2{\%}. Clinical stage was IA in 29.3{\%}, IB in 15.3{\%}, IIA in 1.4{\%}, IIB in 6.2{\%}, IIIA in 11.8{\%}, IIIB in 14.6{\%} and IV in 21.0{\%}. Surgery was performed in 8,454 cases (57.5{\%}). Five-year survival rate was 44.3{\%} for all patients, 14.7{\%} for cases of small cell carcinoma, 46.8{\%} for non small cell carcinoma, 59.6{\%} for surgery cases, 8.5{\%} for no surgery cases, 37.7{\%} for males and 59.0{\%} for females. The rates in clinical stage settings in cases of small cell carcinoma and non small cell carcinoma, was 52.7{\%} and 79.4{\%} for IA, 39.3{\%} and 56.9{\%} for IB, 31.7{\%} and 49.0{\%} for IIA, 29.9{\%} and 42.3{\%} for IIB, 17.2{\%} and 30.9{\%} for IIIA, 12.4{\%} and 16.7{\%} for IIIB and 3.8{\%} and 5.8{\%} for IV, respectively. Conclusion. An analysis of Japanese lung cancer patients registered in 2002 revealed that the most frequent histology type was adenocarcinoma following squamous cell carcinoma and small cell carcinoma. Prognosis in 5 years was superior in cases of female, non small cell lung cancer and surgery to those of male, small cell lung cancer and no surgery, respectively. Further investigation is needed with respect to dependences of those survival differences.",
keywords = "Cancer registration, Lung cancer, Prognosis",
author = "Noriyoshi Sawabata and Hisao Asamura and Tomoyuki Goya and Masaki Mori and Yoichi Nakanishi and Kenji Eguchi and Yoshihiko Koshiishi and Ryosuke Tsuchiya and Meinoshin Okumura and Etsuo Miyaoka and Yoshitaka Fujii",
year = "2009",
month = "12",
doi = "10.2482/haigan.49.975",
language = "English",
volume = "49",
pages = "975--987",
journal = "Japanese Journal of Lung Cancer",
issn = "0386-9628",
publisher = "Japan Lung Cancer Society",
number = "7",

}

TY - JOUR

T1 - A Japanese lung cancer registry study at 2002

T2 - Japanese joint committee for lung cancer registration

AU - Sawabata, Noriyoshi

AU - Asamura, Hisao

AU - Goya, Tomoyuki

AU - Mori, Masaki

AU - Nakanishi, Yoichi

AU - Eguchi, Kenji

AU - Koshiishi, Yoshihiko

AU - Tsuchiya, Ryosuke

AU - Okumura, Meinoshin

AU - Miyaoka, Etsuo

AU - Fujii, Yoshitaka

PY - 2009/12

Y1 - 2009/12

N2 - Objectives. To publicize clinical results of Japanese lung cancer patients registered in 2002. Study Design. In 2002, The Japanese Joint Committee for Lung Cancer Registration conducted a prospective observational study for lung cancer patients registered at starting treatments with follow-ups in 2004 and 2009. At first, 18,552 cases were registered from 358 institutes, while we analyzed 14,695 samples whose living periods could be identified. Results. There were 2 times males as many as females with a mean age of 67.1 years. The most frequent histology was adenocarcinoma in 56.7%, following squamous cell carcinoma in 25.7% and small cell carcinoma in 9.2%. Clinical stage was IA in 29.3%, IB in 15.3%, IIA in 1.4%, IIB in 6.2%, IIIA in 11.8%, IIIB in 14.6% and IV in 21.0%. Surgery was performed in 8,454 cases (57.5%). Five-year survival rate was 44.3% for all patients, 14.7% for cases of small cell carcinoma, 46.8% for non small cell carcinoma, 59.6% for surgery cases, 8.5% for no surgery cases, 37.7% for males and 59.0% for females. The rates in clinical stage settings in cases of small cell carcinoma and non small cell carcinoma, was 52.7% and 79.4% for IA, 39.3% and 56.9% for IB, 31.7% and 49.0% for IIA, 29.9% and 42.3% for IIB, 17.2% and 30.9% for IIIA, 12.4% and 16.7% for IIIB and 3.8% and 5.8% for IV, respectively. Conclusion. An analysis of Japanese lung cancer patients registered in 2002 revealed that the most frequent histology type was adenocarcinoma following squamous cell carcinoma and small cell carcinoma. Prognosis in 5 years was superior in cases of female, non small cell lung cancer and surgery to those of male, small cell lung cancer and no surgery, respectively. Further investigation is needed with respect to dependences of those survival differences.

AB - Objectives. To publicize clinical results of Japanese lung cancer patients registered in 2002. Study Design. In 2002, The Japanese Joint Committee for Lung Cancer Registration conducted a prospective observational study for lung cancer patients registered at starting treatments with follow-ups in 2004 and 2009. At first, 18,552 cases were registered from 358 institutes, while we analyzed 14,695 samples whose living periods could be identified. Results. There were 2 times males as many as females with a mean age of 67.1 years. The most frequent histology was adenocarcinoma in 56.7%, following squamous cell carcinoma in 25.7% and small cell carcinoma in 9.2%. Clinical stage was IA in 29.3%, IB in 15.3%, IIA in 1.4%, IIB in 6.2%, IIIA in 11.8%, IIIB in 14.6% and IV in 21.0%. Surgery was performed in 8,454 cases (57.5%). Five-year survival rate was 44.3% for all patients, 14.7% for cases of small cell carcinoma, 46.8% for non small cell carcinoma, 59.6% for surgery cases, 8.5% for no surgery cases, 37.7% for males and 59.0% for females. The rates in clinical stage settings in cases of small cell carcinoma and non small cell carcinoma, was 52.7% and 79.4% for IA, 39.3% and 56.9% for IB, 31.7% and 49.0% for IIA, 29.9% and 42.3% for IIB, 17.2% and 30.9% for IIIA, 12.4% and 16.7% for IIIB and 3.8% and 5.8% for IV, respectively. Conclusion. An analysis of Japanese lung cancer patients registered in 2002 revealed that the most frequent histology type was adenocarcinoma following squamous cell carcinoma and small cell carcinoma. Prognosis in 5 years was superior in cases of female, non small cell lung cancer and surgery to those of male, small cell lung cancer and no surgery, respectively. Further investigation is needed with respect to dependences of those survival differences.

KW - Cancer registration

KW - Lung cancer

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=77249178331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77249178331&partnerID=8YFLogxK

U2 - 10.2482/haigan.49.975

DO - 10.2482/haigan.49.975

M3 - Article

AN - SCOPUS:77249178331

VL - 49

SP - 975

EP - 987

JO - Japanese Journal of Lung Cancer

JF - Japanese Journal of Lung Cancer

SN - 0386-9628

IS - 7

ER -